Vigafyde Alternatives Compared
Vigafyde (vigabatrin) | Vigabatrin | Vigadrone (vigabatrin) |
|
---|
Vigafyde (vigabatrin) | Vigabatrin | Vigadrone (vigabatrin) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Infantile Spasms. Vigafyde may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Infantile Spasms, Seizure Prevention, Epilepsy, Seizures. Vigabatrin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Infantile Spasms, Seizure Prevention, Epilepsy, Seizures. Vigadrone may also be used for purposes not listed in this medication guide. |
Related suggestions Infantile Spasms
|
|||||||||||||||||||||||
More about Vigafyde (vigabatrin) | More about Vigabatrin | More about Vigadrone (vigabatrin) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Vigabatrin has an average rating of 9.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Vigafyde side effects |
View all Vigabatrin side effects |
View all Vigadrone side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic approved | |||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Vigafyde prices |
View all Vigabatrin prices |
View all Vigadrone prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other vigabatrin brands include: Sabril, Vigadrone, Vigpoder | Sabril, Vigadrone, Vigafyde, Vigpoder | Other vigabatrin brands include: Sabril, Vigafyde, Vigpoder | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
13 hours |
13 hours |
13 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 287 drugs are known to interact with Vigafyde:
|
A total of 287 drugs are known to interact with Vigabatrin:
|
A total of 287 drugs are known to interact with Vigadrone:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 17, 2024 |
August 21, 2009 |
N/A |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.